Evidence map›Paper›PMID 39687897›Full record

ArticleFrontiers in oncology2024

Rare cases of a second recurrence of nephroblastoma with MLLT1 gene mutation: case report and literature review.

Yiling Dai, Xin Chen, Guoqian He, Ju Gao, Xia Guo

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yiling Dai *Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Xin Chen *Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Guoqian HeDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Ju GaoDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
Xia GuoDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephroblastoma or Wilms tumor is the most common tumor of the urinary system in childhood. The survival rate can reach more than 90% after multidisciplinary treatment, but there is still a certain recurrence rate. In recent years, domestic and foreign scholars have analyzed the gene mutations related to the recurrence of nephroblastoma from the genetics or epigenetics perspective. However, few reports on the relationship between

Indexed as

MLLT1 genemutationnephroblastomarecurrenceWilms tumor

Identifiers

PMID39687897
PMCPMC11646860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.